A double-edged function of DDX3, as an oncogene or tumor suppressor, in cancer progression (Review)-Reference-Cited by-同舟云学术

A double-edged function of DDX3, as an oncogene or tumor suppressor, in cancer progression (Review)

Published:2018-01-09 Issue: Volume: Page:
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

He Yu¹,Zhang Dan¹,Yang Yanfang¹,Wang Xixi¹,Zhao Xinyu¹,Zhang Peng²,Zhu Hongxia³,Xu Ningzhi¹,Liang Shufang¹

Affiliation:

1. State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan 610041, P.R. China

2. Department of Urinary Surgery, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan 610041, P.R. China

3. Laboratory of Cell and Molecular Biology and State Key Laboratory of Molecular Oncology, Cancer Institute and Cancer Hospital, Chinese Academy of Medical Sciences, Beijingï¿½100021, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Avenues and Major Achievements in Phytocompounds Research for Glioblastoma Therapy;Molecules;2024-04-08

2. The current (and possible future) role of opioid analgesia in lung cancer surgery;Best Practice & Research Clinical Anaesthesiology;2024-03

3. Prokaryotic Expression and Affinity Purification of DDX3 Protein;Protein & Peptide Letters;2024-03

4. RNA helicase DDX3 regulates RAD51 localization and DNA damage repair in Ewing sarcoma;iScience;2024-02

5. Saturation genome editing of DDX3X clarifies pathogenicity of germline and somatic variation;Nature Communications;2023-12-06